To investigate the potential influence of NLRP4 on the DNA damage response, γ-H2AX foci were examined in pancreatic cancer cells with NLRP4 knockdown and in control cells treated with either DMSO or olaparib (Fig. 3a–c). This evidence concerns the gene H2AX and familial pancreatic carcinoma.